The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Coronary interventions
DANUBIO - a new drug-eluting balloon for the treatment of side branches in bifurcation lesions: six-month angiographic follow-up results of the DEBSIDE trial
Jacques Berland1*, MD; Thierry Lefèvre2, MD, FESC, FSCAI; Philippe Brenot3, MD; Jean Fajadet4, MD; Pascal Motreff5, MD, PhD; Patrice Guerin6, MD, PhD; Patrick Dupouy7, MD; Christian Schandrin8, MD; DEBSIDE trial investigators
1. Clinique Saint-Hilaire, Rouen, France; 2. Institut Hospitalier Jacques Cartier, Massy, France; 3. Centre Cardiologique d’Evecquemont, Evecquemont, France; 4. Clinique Pasteur, Toulouse, France; 5. Hôpital Gabriel Montpied, Clermont-Ferrand, France; 6.
Aims: We aimed to evaluate the role of drug-eluting balloon SB inflation, using the novel DANUBIO balloon, after placement of a drug-eluting stent in the main branch in patients with bifu